Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Capital Expenditures (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Capital Expenditures for 12 consecutive years, with $438000.0 as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 165.45% year-over-year to $438000.0; the TTM value through Mar 2026 reached $991000.0, up 44.46%, while the annual FY2025 figure was $718000.0, 23.45% down from the prior year.
  • Capital Expenditures hit $438000.0 in Q1 2026 for Wave Life Sciences, up from -$1000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $492000.0 in Q2 2022 and bottomed at -$1000.0 in Q4 2025.
  • Average Capital Expenditures over 5 years is $268823.5, with a median of $248000.0 recorded in 2025.
  • Year-over-year, Capital Expenditures soared 1260.0% in 2022 and then plummeted 101.16% in 2025.
  • Wave Life Sciences' Capital Expenditures stood at $204000.0 in 2022, then soared by 74.51% to $356000.0 in 2023, then tumbled by 75.84% to $86000.0 in 2024, then tumbled by 101.16% to -$1000.0 in 2025, then skyrocketed by 43900.0% to $438000.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $438000.0, -$1000.0, and $248000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.